Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Partial 3-beta-hydroxysteroid dehydrogenase deficiencies].

B Ducornet1, J Duprey

  • 1Policlinique, Hôpital Ambroise-Paré, Boulogne.

Annales D'Endocrinologie
|January 1, 1992
PubMed
Summary

Partial 3 beta-hydroxysteroid dehydrogenase deficiency presents in classical and late-onset forms. Diagnosis involves specific steroid ratios, with treatment focusing on glucocorticoids and cyproterone acetate.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A new case of 2-methylacetoacetyl-CoA thiolase deficiency?

Journal of inherited metabolic disease·2000
Same author

[Subclinical thyroid disorders: strategies].

La Revue de medecine interne·1999
Same author

Major circadian variations of glucose homeostasis in a patient with Rabson-Mendenhall syndrome and primary insulin resistance due to a mutation (Cys284-->Tyr) in the insulin receptor alpha-subunit.

Pediatric research·1997
Same author

[Reliability of needle biopsy of solitary thyroid nodules in view of surgical indications].

La Revue de medecine interne·1996
Same author

[Presence of ophthalmopathy in all cases of Basedow disease?].

Annales d'endocrinologie·1996
Same author

[Hypothyroidism and blocking antibodies].

Annales de medecine interne·1995

Area of Science:

  • Endocrinology
  • Steroidogenesis
  • Genetics

Context:

  • Partial 3 beta-hydroxysteroid dehydrogenase (3β-HSD) deficiency affects adrenal and gonadal steroid production.
  • Recognized forms include classical (salt-losing, ambiguous genitalia) and late-onset (hyperandrogenism, oligomenorrhea).
  • This autosomal recessive condition impacts both adrenal and gonadal tissues.

Purpose:

  • To provide an overview of partial 3 beta-hydroxysteroid dehydrogenase deficiency.
  • To highlight diagnostic criteria and therapeutic strategies.
  • To discuss the association with polycystic ovary syndrome.

Summary:

  • Classical 3β-HSD deficiency causes salt-losing syndrome or ambiguous genitalia.
  • Late-onset forms are increasingly diagnosed in patients with hyperandrogenism and/or oligomenorrhea.
  • Diagnostic confirmation relies on elevated delta 5/delta 4 steroid ratios, specifically 17-hydroxypregnenolone/17-hydroxyprogesterone.

Impact:

  • Glucocorticoid therapy can restore menses and ovulation.
  • Cyproterone acetate effectively manages cutaneous hyperandrogenism symptoms.
  • Understanding this deficiency is crucial for diagnosing and managing reproductive and adrenal disorders.

Related Experiment Videos